FDA's Office Of Prescription Drug Promotion Reviews Amgen's Submitted Video For VECTIBIX Injection For Intravenous Use; FDA Determines Video Is False Or Misleading And Breaches Federal Food, Drug, And Cosmetic Act

Loading news article.

FDA's Office Of Prescription Drug Promotion Reviews Amgen's Submitted Video For VECTIBIX Injection For Intravenous Use; FDA Determines Video Is False Or Misleading And Breaches Federal Food, Drug, And Cosmetic Act | WAPE

FDA's Office Of Prescription Drug Promotion Reviews Amgen's Submitted Video For VECTIBIX Injection For Intravenous Use; FDA Determines Video Is False Or Misleading And Breaches Federal Food, Drug, And Cosmetic Act

Article summary

Related companies

Comments —